feedzop-word-mark-logo
searchLogin
Feedzop
homeFor YouIndiaIndia
You
bookmarksYour BookmarkshashtagYour Topics
Trending
trending

Fentanyl crisis worsens in Philadelphia

trending

Vinod Kumar Shukla dies

trending

PM Modi meets Neeraj Chopra

trending

Japan H3 rocket launch fails

trending

Punjab teachers unpaid for months

trending

RRB Group D exam rescheduled

trending

Jyothi Yarraji wins Asian gold

trending

Bihar STET result expected soon

trending

KARTET Result 2025 announced

Terms of UsePrivacy PolicyAboutJobsPartner With Us

© 2025 Advergame Technologies Pvt. Ltd. ("ATPL"). Gamezop ® & Quizzop ® are registered trademarks of ATPL.

Gamezop is a plug-and-play gaming platform that any app or website can integrate to bring casual gaming for its users. Gamezop also operates Quizzop, a quizzing platform, that digital products can add as a trivia section.

Over 5,000 products from more than 70 countries have integrated Gamezop and Quizzop. These include Amazon, Samsung Internet, Snap, Tata Play, AccuWeather, Paytm, Gulf News, and Branch.

Games and trivia increase user engagement significantly within all kinds of apps and websites, besides opening a new stream of advertising revenue. Gamezop and Quizzop take 30 minutes to integrate and can be used for free: both by the products integrating them and end users

Increase ad revenue and engagement on your app / website with games, quizzes, astrology, and cricket content. Visit: business.gamezop.com

Property Code: 5571

You may also like

Day-Care Bone Marrow Transplants Slash Costs

2 hours ago

article image

Cancer Patients Fund Own Chemo Amid NHS Wait Woes

21 Dec • 15 reads

article image

Zambian Nurse Survives Cancer, Cardiac Arrests in India

20 Dec • 21 reads

article image

Cancer-Free Boy's Christmas Miracle: Home for the Holidays!

21 Dec • 15 reads

article image

Leukaemia Battle: Teen Finds Match After Family's Call

17 Dec • 38 reads

article image

Home / Health / Cancer Fund Saves 176 Children's Lives

Cancer Fund Saves 176 Children's Lives

19 Dec

•

Summary

  • A philanthropic fund has saved 176 children with blood cancer.
  • The fund registered 272 children for multi-stage, long-term treatment.
  • A private bank contributed ₹5.25 crore through CSR initiatives.
Cancer Fund Saves 176 Children's Lives

A vital philanthropic fund established a decade ago has significantly impacted childhood cancer treatment. The "Donate a Life" initiative at Bhagwan Mahaveer Cancer Hospital has provided essential multi-stage treatment, lasting one to two years, for 272 children diagnosed with blood cancer. As of December 18, 2025, this program has successfully saved 176 young lives, with 168 children fully cured and eight others showing encouraging progress under current care.

The program, initiated in August 2014, addresses the critical need for extended medical care, which can cost up to ₹5 lakh per child. Many families faced financial barriers, but contributions from philanthropists, trusts, donors, and corporations, including ₹5.25 crore from a private bank's CSR fund over five years, have made this possible. The focus is on curable cancers like acute lymphoblastic leukaemia, acute promyelocytic leukaemia, and Hodgkin's lymphoma, in children under 14.

Hospital director Dr. S.G. Kabra emphasized the ethical imperative of treating curable cancers, stating it is a child's entitlement and unacceptable to let poverty dictate survival. The fund covers all treatment costs, including medicines and investigations, enabling children like 16-year-old Alveera and 20-year-old Divyansh Agarwal to lead normal, productive lives post-treatment, becoming assets to society.

Disclaimer: This story has been auto-aggregated and auto-summarised by a computer program. This story has not been edited or created by the Feedzop team.
The 'Donate a Life' fund has registered 272 children and successfully saved 176 lives.
The estimated cost for complete cancer treatment can reach ₹5 lakh per child.
The fund treats curable cancers like acute lymphoblastic leukaemia, acute promyelocytic leukaemia, and Hodgkin's lymphoma.

Read more news on

Healthside-arrow